Postoperative Analgesic Effects of Using Dexmedetomidine for Ultrasound Guided Thoracic Paravertebral Block
NCT ID: NCT02544893
Last Updated: 2016-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
93 participants
INTERVENTIONAL
2015-09-30
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Analgesic Effects of Dexmedetomidine for Transversus Abdominis Plane Block
NCT02064530
Ultrasound Guided Retrolaminar Versus Erector Spinae Plane Block for Postoperative Analgesia
NCT04531215
Morphine and Dexmedetomidine as Adjuvants to Bupivacaine in Ultrasound-guided Erector Spinae Plane Block for Open Subcostal Renal Surgeries
NCT07012590
Assessment of the Impact of Two Dexmedetomidine Dosages Added with Bupivacaine in Ultrasound-Guided Transversus Abdominis Plane Block for Postoperative Analgesia Following Inguinal Hernia Repair
NCT06703229
Erector Spinae Block -Dexmedetomidine
NCT06264739
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bupivacaine
0,5% 20 ml bupivacaine added 0.9% 1 ml serum physiologic on paravertebral block
bupivacaine
21 ml 0.5 %bupivacaine is applied paravertebral space
dexmedetomidine
100 mcg dexmedetomidine added to 0,5% 20 ml bupivacaine on paravertebral block
dexmedetomidin
1 ml dexmedetomidin + 20 ml 0.5 % bupivacaine are applied paravertebral space
serum phsyologic
0,9% 21 ml serum physiologic
serum physiologic
21 ml serum physiologic is applied paravertebral space
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bupivacaine
21 ml 0.5 %bupivacaine is applied paravertebral space
dexmedetomidin
1 ml dexmedetomidin + 20 ml 0.5 % bupivacaine are applied paravertebral space
serum physiologic
21 ml serum physiologic is applied paravertebral space
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-65 aged
* patient undergoing thoracotomy
Exclusion Criteria
* bupivacaine and dexmedetomidine allergies
* coagulopathy
* infection at the needle insertion side
* chronic liver and kidney disease
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TC Erciyes University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Esra Nur Ünalan
resident
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
esra n ünalan, resident
Role: PRINCIPAL_INVESTIGATOR
TC Erciyes University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erciyes University Medicine Faculty
Kayseri, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014/649
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.